IXACTILE
DEAD

Serial Number

79363506

Owner

Ixaka France, S.A.

Filing Date

Oct 24, 2022

Add to watchlist:

No watchlists yet
View on USPTO

IXACTILE Trademark

Serial Number: 79363506

IXACTILE is a trademark filed by Ixaka France, S.A. on October 24, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Ixaka France, S.A.

Villejuif Bio Park,

Entity Type: 98

Trademark Details

Filing Date

October 24, 2022

Registration Date

Not Registered

Goods & Services

Production of cell lines for use in the manufacture of biopharmaceuticals; protein fabrication, production, and manufacture for others; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; Nanoparticles manufacturing

Medicines; pharmaceutical and veterinary preparations; chemical, analytical and diagnostic reagents for in vivo use, for medical purposes; chemicals for use in medical research, and medical or veterinary diagnosis; pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical products for the prevention and treatment of cancer, cardiovascular diseases and genetic disorders; pharmaceutical and medical preparations and substances; drug delivery agents; drug delivery compounds that facilitate the delivery of pharmaceutical products; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical products; drug delivery agents in the form of tablet coatings that facilitate the delivery of pharmaceutical products

Chemicals for use in science, scientific research and for laboratory use; analytical and diagnostic reagents for in vitro use

Surgical, medical, therapeutic, dental and veterinary apparatus and instruments; drug delivery devices; medical devices used to deliver drugs, drug delivery solutions and suspensions, genes, polymers and biologics to the body; diagnostic apparatus for medical purposes; dispensing devices for the prolonged release of active agents for medical uses; inhalers for medical purposes; parts, fittings and accessories for all the aforesaid goods

Scientific, medical and industrial research and development services; clinical research; laboratory research; research and development of new drugs and clinical products; analysis of materials; chemical analysis; laboratory services; laboratory testing services; medical laboratory services; information and advisory services relating to the foregoing, including such services provided on-line from a computer network or the internet; research and development services for pharmaceuticals and for the treatment of diseases and injuries; genetic engineering services; genetic research; scientific and technological services and research and development relating thereto; genetic testing for scientific research purposes; medical and pharmacological research services; research and development in the fields of biotechnology, biopharmaceuticals and gene therapy; clinical trials; research and development of pharmaceutical preparations; development of technological platforms services for nanoparticles manufacturing

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 4, 2025 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 19, 2025 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 19, 2025 FICR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 18, 2024 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 18, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 18, 2024 ABN2
ASSIGNED TO EXAMINER
Jan 12, 2024 DOCK
REFUSAL PROCESSED BY IB
Sep 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 4, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 4, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 15, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 14, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 28, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 23, 2023 REPR